Skip to main content

Gold, Regionals, Bios & Gas

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

πŸ“Œ International Tower Hill Mines $THM β€” Paulson & Company purchased $12.58 Million via Form 4.

A meaningful add from John Paulson’s gold-focused hedge fund, increasing exposure to the junior miner as the stock continues carving out a deep base.

πŸ“Œ Home Bancshares $HOMB β€” The Chairman & CEO purchased $2.70 Million via Form 4.

A notable CEO buy in the regional bank, with the top operator in the business putting personal capital to work as the stock threatens to complete a decade-long base.

Here’s The Hot Corner, with data from April 20, 2026:

πŸ“Œ Spyre Therapeutics $SYRE β€” Fairmount Funds Management increased its stake from 5.18% to 9.99% via 13D.

The healthcare-focused investor continues building toward a 10% position in one of the strongest biotech stocks in the market, a notable show of conviction.

πŸ“Œ Golar LNG $GLNG β€” Toms Capital Investment Management filed an original 13G at 6.10%.

A fresh institutional position well above the 5% threshold in the LNG infrastructure name, adding another layer of sponsorship to a stock already on the radar.